Price Discrimination Across Indications in the Pharmaceutical Industry: The Case of Finasteride

4 Pages Posted: 15 Dec 2005

See all articles by Cem Baslevent

Cem Baslevent

Istanbul Bilgi University - Department of Economics

Date Written: December 2005

Abstract

This paper examines the price differential between two prescription drugs (Proscar and Propecia) which contain the same active ingredient (finasteride) in different dosages. It is argued that the price differential is an example of price discrimination across indications of the same substance.

Keywords: price discrimination, pharmaceuticals, market power

JEL Classification: D40, L11, L65

Suggested Citation

Baslevent, Cem, Price Discrimination Across Indications in the Pharmaceutical Industry: The Case of Finasteride (December 2005). Available at SSRN: https://ssrn.com/abstract=869689 or http://dx.doi.org/10.2139/ssrn.869689

Cem Baslevent (Contact Author)

Istanbul Bilgi University - Department of Economics ( email )

Kustepe
Susli
Istanbul, 80310
Turkey

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
278
Abstract Views
2,413
rank
119,941
PlumX Metrics